跨国生物科技公司联拓生物近日完成美国纳斯达克上市，募集资金约3.25亿美元。中伦律师事务所、瑞格律师事务所担任发行人律师；通商律师事务所、科律律师事务所则为联席承销商提供法律意见。

联拓生物成立于2019年，是一家专注于创新性药物研发的生物科技公司，主要面向中国和亚洲其他主要市场。

中伦团队由合伙人赵靖、贾海波牵头领导；瑞格团队则由合伙人吴延凯、Melissa S. Rones、王凯玲牵头领导。

此次IPO项目中的联席承销商包括高盛、富瑞金融（Jefferies LLC）、美银证券、瑞杰金融（Raymond James）。Travers Thorp Alberga担任发行人的离岸律师。

Ropes & Gray, Cooley led on Chinese bio-medicine maker’s $325mln Nasdaq IPO

Ropes & Gray and Zhong Lun Law Firm have advised LianBio, a Shanghai-based biological technology company, on its $325 million IPO in Nasdaq, with Cooley and Commerce & Finance Law Offices advising the joint underwriters.

Established in 2019, LianBio focuses on developing innovative medicine targeting at China and other major markets in Asia.

The Zhong Lun team was led by partners Zhao Jing and Jia Haibo, while the Ropes & Gray team was led by partners Eric Wu, Melissa S. Rones, and Katherine Wang.

The joint underwriters were Goldman Sachs, Jefferies, BofA Securities, and Raymond James. Travers Thorp Alberga served as the issuer’s offshore lawyer.

To contact the editorial team, please email ALBEditor@thomsonreuters.com.